0001062993-23-016717.txt : 20230817 0001062993-23-016717.hdr.sgml : 20230817 20230817162419 ACCESSION NUMBER: 0001062993-23-016717 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230815 FILED AS OF DATE: 20230817 DATE AS OF CHANGE: 20230817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hippel James CENTRAL INDEX KEY: 0001603594 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 231182245 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-08-15 0000842023 BIO-TECHNE Corp TECH 0001603594 Hippel James 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 0 1 0 0 CFO 0 Common Stock 57561 D Stock Options (Right to Buy) 31.26 2024-08-09 Common Stock 189156 189156 D Stock Options (Right to Buy) 44.33 2025-08-08 Common Stock 72264 72264 D Stock Options (Right to Buy) 44.33 2025-08-08 Common Stock 96356 96356 D Stock Options (Right to Buy) 47.60 2026-08-07 Common Stock 79744 79744 D Stock Options (Right to Buy) 47.60 2026-08-07 Common Stock 106324 106324 D Stock Options (Right to Buy) 66.97 2027-08-05 Common Stock 57440 57440 D Stock Options (Right to Buy) 66.97 2027-08-05 Common Stock 33300 33300 D Restricted Stock Units Common Stock 12876 0 D Stock Options (Right to Buy) 66.97 2027-08-05 Common Stock 76588 76588 D Restricted Stock Units Common Stock 7780 7780 D Stock Options (Right to Buy) 120.46 2028-08-06 Common Stock 30400 30400 D Stock Options (Right to Buy) 120.46 2028-08-06 Common Stock 40536 40536 D Restricted Stock Units Common Stock 10912 10912 D Stock Options (Right to Buy) 94.52 2029-08-15 Common Stock 33916 33916 D Stock Options (Right to Buy) 94.52 2029-08-15 Common Stock 45220 45220 D Restricted Stock Units 2023-08-15 4 A 0 12798 0 A Common Stock 12798 12798 D Stock Options (Right to Buy) 84.61 2023-08-15 4 A 0 34442 0 A 2030-08-15 Common Stock 34442 34442 D Stock Options (Right to Buy) 84.61 2023-08-15 4 A 0 45923 0 A 2030-08-15 Common Stock 45923 45923 D Fully exercisable. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. On 8/5/2023, the Board of Directors certified vesting of 12,876 performance RSUs. Options to purchase 57,440 shares are vested. Options to purchase 19,148 shares vest on 8/5/2024. Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 20,268 shares are vested. Options to purchase 10,136 shares vest on 8/6/2024 and options to purchase 10,134 shares vest on 8/6/2025. Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 11,304 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026 and options to purchase 11,308 shares vest on 8/15/2024. Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/27, and options to purchase 11,480 shares vest on 8/15/2026. /s/ Andrew Nick, Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed 2023-08-17